Phenylpiracetam vs Piracetam

Mechanism

Atypical dopamine reuptake inhibitor with additional phenethylamine-like stimulatory properties. Increases the density of acetylcholine, NMDA, GABA, and dopamine receptors in the brain. The phenyl group addition to the piracetam backbone enables blood-brain barrier penetration at 20-60x greater potency than piracetam, with added psychostimulant and cold-tolerance properties.

Standard Dosing

100-300 mg/day divided into 1-2 doses

Timing

Morning or early afternoon; avoid evening use due to stimulant effects. Take with or without food.

Cycle Duration

Use sparingly — tolerance develops rapidly. Best cycled 2 weeks on, 2 weeks off, or reserved for acute-need situations.

Side Effects

• Insomnia
• Irritability
• Headache
• Appetite suppression
• Rapid tolerance development

Contraindications

• Cardiac arrhythmias
• Severe hypertension
• Anxiety disorders
• History of psychosis

Best Stacking Partners

Mechanism

Positive allosteric modulator of AMPA receptors, binding at a unique site along the dimer interface to reduce desensitization and deactivation. Inhibits N-type calcium channels at clinically relevant CNS concentrations. Enhances membrane fluidity of neuronal phospholipids and modulates neurotransmission across cholinergic and glutamatergic systems.

Standard Dosing

1200-4800 mg/day divided into 2-3 doses

Timing

With or without food; split doses morning and afternoon to maintain plasma levels

Cycle Duration

Cycles of 8-12 weeks on, 4 weeks off; or ongoing with periodic reassessment

Side Effects

• Headache (often from inadequate choline)
• Insomnia
• GI discomfort
• Irritability at high doses

Contraindications

• Severe renal impairment (renally excreted)
• Huntington's disease
• Cerebral hemorrhage

Best Stacking Partners